[Implantation of iris-claw phakic anterior chamber intraocular lenses for the correction of severe myopia].
To evaluate the efficiency, predictability, and complications after implantation of iris-clawed phakic intraocular lenses (PIOL) for the correction of severe myopia. In this study, 12 cases (21 eyes) with myopia at -11.5 to -21.0 diopters (D) were implanted with Verisyse iris-clawed PIOL with an optical zone of 6.0 or 5.5 mm. All cases have been followed-up for more than 6 months. Uncorrected visual acuity (UCVA), best spectacled-corrected visual acuity (BSCVA), refraction, intraocular pressure, corneal topography, contour of pupil, corneal endothelial count, PIOL IOL position and pigment deposits on the surface of IOL were observed. The mean follow-up period was (13.2 +/- 2.14) months. After 12 months of follow-up, 17 eyes were investigated and no eyes experienced a loss in BSCVA. UCVA was significantly improved, Five eyes (29.41%) gained 1 line as compared to their preoperative BSCVA, 4 eyes (23.53%) gained 2 lines, 3 eyes (17.65%) gained 3 lines and 2 eyes (11.76%) gained 4 lines. BSCVA was significantly improved, 4 eyes (23.53%) gained 1 or more lines compared to their preoperative BSCVA, 2 eyes (11.76%) gained 2 lines, 2 eyes (11.76%) gained 3 lines, 2 eyes (11.76%) gained 4 lines and 5 eyes (29.41%) gained 5 or more lines. There was no statistically significant difference between pre- and 6 m or 12 m post-operative intraocular pressure and corneal endothelial density (P > 0.05). Iris-clawed phakic intraocular lenses (PIOL) is an effective, safe and predictable procedure for the correction of severe myopia. Follow-up study is still required for the evaluation of long-term results.